Package Leaflet: Information for the User
Repaglinida Teva 0.5mg tablets EFGRepaglinida Teva 1mg tablets EFGRepaglinida Teva 2mg tablets EFGrepaglinida
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Repaglinida Teva is an oral antidiabetic medicine that contains repaglinide, which helps your pancreas produce more insulin and lower your blood sugar (glucose) levels.
Type 2 diabetesis a disease in which the pancreas does not produce enough insulin to control blood sugar levels or in which the body does not respond normally to the insulin it produces.
Repaglinida Teva is used to control type 2 diabetes in adults, as a supplement to diet and exercise: treatment should be initiated if diet, physical exercise, and weight reduction alone have not been sufficient to control (or reduce) blood sugar levels. Repaglinida Teva may also be administered with metformin, another diabetes medication.
It has been shown that repaglinide reduces blood sugar levels, which helps prevent diabetes complications.
Do not take Repaglinida Teva
Warnings and precautions
Consult your doctor before taking Repaglinida Teva:
Consult your doctor ifany of the above cases apply to you, Repaglinida Teva may not be suitable for you. Your doctor will advise you.
Children and adolescents
Do not take this medicine if you are under 18 years old.
If you have hypoglycaemia (low blood sugar)
You may experience hypoglycaemia if your blood sugar levels are too low. This can happen if:
Warning signs of hypoglycaemiaappear suddenly and can be: cold sweat; cool, pale skin; headache; palpitations; nausea; excessive hunger; temporary visual disturbances; fatigue; unusual weakness and tiredness; nervousness or tremors; anxiety; confusion and difficulty concentrating.
If your blood sugar levels are low or if you feel you are going to have hypoglycaemia:take glucose tablets or a sugary product or drink and then rest.
When hypoglycaemia symptoms disappear or when blood sugar levelsstabilizecontinue treatment with Repaglinida Teva.
Inform others that you are diabeticand if you lose consciousnessdue to hypoglycaemia, they should lay you on your side and seek immediate medical attention. They should not give you anything to eat or drink, as you may choke.
If your blood sugar levels are too high
Your blood sugar levels may be too high (hyperglycaemia). This can happen:
Warning signs of high blood sugarappear gradually. These include: excessive urination, thirst, dry skin, and a dry mouth feeling. Inform your doctor. You may need to adjust the dose of Repaglinida, your diet, or exercise.
Other medicines and Repaglinida Teva
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If your doctor prescribes it, you can take Repaglinida Teva with metformin, another diabetes medication.
If you take gemfibrozil (used to lower blood fat levels), you should not take Repaglinida Teva.
Your body's response to Repaglinida Teva may change if you take other medicines, especially:
Using Repaglinida Teva with alcohol
Alcohol may alter Repaglinida Teva's ability to lower blood sugar levels. Be aware of hypoglycaemia symptoms.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.
You should not take Repaglinida Teva if you are pregnant or planning to become pregnant.
You should not take Repaglinida Teva if you are breastfeeding.
Driving and using machines
Your ability to drive or operate machines may be affected if your blood sugar levels are low or high. Be aware that you may put yourself or others at risk. Consult your doctor about driving a car if:
Follow the administration instructions of this medicine exactly as prescribed by your doctor. If you are unsure, consult your doctor again.
Your doctor will calculate your dose.
Do not take more Repaglinida Teva than your doctor has recommended.
If you take more Repaglinida Teva than you should
If you take too many tablets, your blood sugar levels may become too low and cause hypoglycaemia. Please read what hypoglycaemia is and how to treat it in the section If you have hypoglycaemia.
If you forget to take Repaglinida Teva
If you forget to take a dose, take the next dose as you normally would, do not take a double dose to make up for the forgotten doses.
If you stop taking Repaglinida Teva
Be aware that the desired effect will not be achieved if you stop taking Repaglinida Teva. Your diabetes may worsen. If any changes to your treatment are necessary, consult your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Hypoglycaemia
The most common side effect is hypoglycaemia, which can affect up to 1 in 10 patients (see If you have hypoglycaemiain section 2). Hypoglycaemic reactions are normally mild or moderate but can occasionally lead to loss of consciousness or hypoglycaemic coma. If this happens, you need immediate medical attention.
Allergic reactions
Cases of allergy are very rare (may affect up to 1 in 10,000 patients). Symptoms such as swelling, difficulty breathing, palpitations, dizziness symptoms, and sweating may be signs of an anaphylactic reaction. Contact your doctor immediately.
Other side effects
Common (may affect up to 1 in 10 patients)
Rare(may affect up to 1 in 1,000 patients)
Very rare(may affect up to 1 in 10,000 patients)
Frequency not known
Reporting of side effects:
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
Store in the original package to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Repaglinida Teva
Each Repaglinida Teva 0.5 mg tablet contains 0.5 mg of repaglinide.
Each Repaglinida Teva 1 mg tablet contains 1 mg of repaglinide.
Each Repaglinida Teva 2 mg tablet contains 2 mg of repaglinide.
Appearance of the Product and Package Contents
The Repaglinida Teva 0.5 mg tablets are light blue/blue, capsule-shaped, engraved with "93" on one side and "210" on the other side of the tablet.
The Repaglinida Teva 1 mg tablets are yellow/light yellow, capsule-shaped, engraved with "93" on one side and "211" on the other side of the tablet.
The Repaglinida Teva 2 mg tablets are peach, speckled, capsule-shaped, engraved with "93" on one side and "212" on the other side of the tablet.
Repaglinida Teva is available in pack sizes of 30, 90, 120, 270 and 360 tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder:
Teva B.V.
Swensweg 5
2031 GA Haarlem
Netherlands
Manufacturer:
Teva Pharmaceutical Works Private Limited Company
Pallagi út 13.
Debrecen H-4042
Hungary
Teva Pharmaceuticals Works Private Limited Company
H-2100 Gödöllő,
Táncsics Mihály út 82
Hungary
Teva UK Ltd
Brampton Road
Hampden Park
Eastbourne,
East Sussex
BN22 9AG,
United Kingdom
Pharmachemie B.V.
Swensweg 5
2031 GA Haarlem
Netherlands
GALIEN LPS
98 rue Bellocier
89100 Sens
France
Merckle GmbH
Ludwig-Merckle-Straße 3,
89143 Blaubeuren-Weiler
Germany
TEVA PHARMA S.L.U
C/ C, n° 4, Polígono Industrial Malpica,
50016 Zaragoza
Spain
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
Belgium Teva Pharma Belgium N.V./S.A./AG Tel: +32 3 820 73 73 | Lithuania UAB “Sicor Biotech” Tel: +370 5 266 0203 |
Bulgaria ???? ????????????? ???????? ???? Tel: +359 2 489 95 82 | Luxembourg Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 3 820 73 73 |
Czech Republic Teva Pharmaceuticals CR, s.r.o. Tel: +420 251 007 111 | Hungary Teva Gyógyszergyár Zrt. Tel.: +36 1 288 64 00 |
Denmark Teva Denmark A/S Tlf: +45 44 98 55 11 | Malta Teva Pharmaceuticals Ireland, Ireland Tel: +44 2075407117 |
Germany Teva GmbH Tel: +49 731 402 08 | Netherlands Teva Nederland B.V. Tel: +31 800 0228 400 |
Estonia Teva Eesti esindus UAB Sicor Biotech Eesti filiaal Tel: +372 6610801 | Norway Teva Norway AS Tlf: +47 66 77 55 90 |
Greece Teva Ελλάς Α.Ε. Τηλ: +30 210 72 79 099 | Austria ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1 97 007 |
Spain Teva Pharma, S.L.U Tél: +34 91 387 32 80 | Poland Teva Pharmaceuticals Polska Sp. z o.o. Tel.: +48 22 345 93 00 |
France Teva Santé Tél: +33 1 55 91 7800 | Portugal Teva Pharma - Produtos Farmacêuticos Lda Tel: +351 21 476 75 50 |
Croatia Pliva Hrvatska d.o.o. Tel: +385 1 37 20 000 | Romania Teva Pharmaceuticals S.R.L Tel: +40 21 230 65 24 |
Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407117 | Slovenia Pliva Ljubljana d.o.o. Tel: +386 1 58 90 390 |
Iceland Teva Pharma Iceland ehf. Sími: +354 5503300 | Slovakia TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 2 5726 7911 |
Italy Teva Italia S.r.l. Tel: +39 028917981 | Finland Teva Finland Oy Puh/Tel: +358 201805900 |
Cyprus Specifar A.B.E.E. Greece Τηλ: +30 2118805000 | Sweden Teva Sweden AB Tel: +46 42 12 11 00 |
Latvia UAB Teva Baltics filiale Latvija Tel: +371 67323666 | United Kingdom(Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
This leaflet was approved on
Other sources of information
Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu